Pay Pay Securities Corp Invitae Corp Transaction History

Pay Pay Securities Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 17, 2024	BUY	$0.01 - $0.61 $67 - $4,141	6,789 Added 64.5%	17,314 $190,000
Q4 2023 Jan 30, 2024	SELL	$0.42 - $0.72 $8,949 - $15,341	-21,308 Reduced 66.94%	10,525 $6.6 Million
Q3 2023 Oct 30, 2023	BUY	$0.6 - $1.53 $18,928 - $48,268	31,548 Added 11069.47%	31,833 $19.4 Million
Q2 2023 Jul 27, 2023	BUY	$1.05 - $1.63 $59 - $92	57 Added 25.0%	285 $322,000
Q1 2023 Apr 20, 2023	BUY	$1.2 - $2.73 $70 - $161	59 Added 34.91%	228 $308,000
Q4 2022 Feb 02, 2023	BUY	$1.71 - $3.61 $288 - $610	169 New	169 $314,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Pay Pay Securities Corp, based on Form 13F filings with the SEC.

Stay updated on Pay Pay Securities Corp with notifications on news.